HARVARD MEMORIAL HOSPITAL
1. Target Overview & Investment Thesis
HARVARD MEMORIAL HOSPITAL is a 13-bed rural/critical access in MC HENRY, IL with $30.4M in net patient revenue and a 12.5% operating margin. The hospital serves a payer mix of 46.5% Medicare, 2.5% Medicaid, and 51.0% commercial.
Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.5% to 19.8% (+736bps).
| Net Revenue HCRIS | $30.4M |
| Current EBITDA COMPUTED | $3.8M |
| Operating Margin COMPUTED | 12.5% |
| Occupancy HCRIS | 12.8% |
| Revenue / Bed COMPUTED | $2.3M |
| Net-to-Gross HCRIS | 36.5% |
| Distress Probability ML | 55.9% |
2. Market Context & Competitive Position
IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 12.5% places it above the state median. Among 53 size-comparable peers (6-26 beds), the median margin is -0.4%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (6-26), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HARVARD MEMORIAL HOSPITAL (Target) | IL | 13 | $30.4M | 12.5% |
| GIBSON AREA HOSPITAL AND HEALT | IL | 25 | $125.0M | -6.7% |
| PARIS COMMUNITY HOSPITAL | IL | 25 | $100.7M | -4.2% |
| SAINT JOSEPH MEMORIAL HOSPITAL | IL | 25 | $86.0M | 33.9% |
| WABASH GENERAL HOSPITAL | IL | 25 | $71.8M | 4.5% |
| HOOPESTON COMMUNITY MEMORIAL H | IL | 22 | $71.5M | -5.2% |
| CRAWFORD MEMORIAL HOSPITAL | IL | 25 | $67.7M | 2.9% |
| ST. FRANCIS HOSPITAL | IL | 25 | $61.6M | 17.4% |
| LINCOLN MEMORIAL HOSPITAL | IL | 25 | $61.5M | 14.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $639K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $608K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $602K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $370K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $19K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $3.8M |
| + RCM Uplift | +$2.2M |
| Pro Forma EBITDA | $6.0M |
| Current Margin | 12.5% |
| Pro Forma Margin | 19.8% |
| WC Released (1x) | $1.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $5.8M | $47.4M | 8.12x | 52.0% |
| Base (11x exit) | 10.0x | 11.0x | $5.8M | $54.0M | 9.26x | 56.1% |
| Bull Case | 9.0x | 11.0x | $5.2M | $63.3M | 12.06x | 64.5% |
| Bull (12x exit) | 9.0x | 12.0x | $5.2M | $70.6M | 13.45x | 68.2% |
| Bear Case | 11.0x | 10.0x | $6.4M | $34.3M | 5.35x | 39.8% |
| Bear (11x exit) | 11.0x | 11.0x | $6.4M | $39.8M | 6.21x | 44.1% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 12.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 55.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 6-26 beds
- Same-state prioritization (n=54)
- Comp margins: P25=-5.9% / P50=-0.4% / P75=8.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.